March 18, 2026

Specialty distribution: An integrated approach to pharmaceutical distribution

By Innomar Strategies

Innomar Strategies’ integrated distribution model is designed to optimize supply chain efficiency and improve product access. In this video, Gohar Alam, Senior Director of 3PL and Specialty Logistics, discusses how our specialty wholesale services complement 3PL operations to minimize lead times, reduce freight costs, and mitigate product loss. With robust inventory management and advanced data insights, we provide flexible solutions tailored to meet client needs while ensuring safety and efficiency in drug distribution across Canada.

Transcript of ‘Specialty distribution: An integrated approach to pharmaceutical distribution’

How does Innomar's integrated distribution model support supply chain efficiency and patient care?

At Innomar, our proven integrated model is designed to deliver customized solutions to improve product access, increase supply chain efficiency, and enhance patient care by minimizing lead times across various therapeutic classes.

We are a trusted expert in specialty pharmaceuticals within Canada, with an unwavering commitment to patients and their safety.

Our specialty wholesale model complements our 3PL operations by providing clients with a smooth transition that allows us to provide the highest level of service that carries over into our Patient Support Program components while minimizing freight costs and risk of product loss.

Whether you require standalone services or a comprehensive, integrated approach, our model offers the flexibility to meet your needs.

Innomar’s Specialty Wholesale distribution services also provide robust inventory management solutions coupled with advanced data capture and insights.

These services are key components in the drug distribution journey and provide clients with the information needed to make informed decisions about business operations.

With Innomar, you gain a strategic vendor committed to maximizing the efficiency and safety of your drug distribution in Canada.

The information provided in this piece does not constitute legal or medical advice. Innomar Strategies Inc. and its parent Cencora, Inc. strongly encourage the audience to review available information related to the topics discussed to rely on their own experience and expertise in making decisions related thereto. Further, the contents of this piece are owned by Innomar Strategies, and reproduction is not permitted without the consent of Innomar Strategies.

Topics:

Distribution